REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGEN INVESTMENT MANAGEMENT, LP | 53,988 | $1,366,436 | 0.20% |
| THRIVENT FINANCIAL FOR LUTHERANS | 3,247,319 | $82,189 | 0.19% |
| HARBOR CAPITAL ADVISORS, INC. | 31,692 | $802,125 | 0.16% |
| EULAV Asset Management | 160,000 | $4,049,600 | 0.15% |
| PICTON MAHONEY ASSET MANAGEMENT | 134,388 | $3,403 | 0.15% |
| CASTLEARK MANAGEMENT LLC | 125,727 | $3,182,150 | 0.14% |
| HAP Trading, LLC | 250,000 | $800,000 | 0.14% |
| Legato Capital Management LLC | 39,766 | $1,006,477 | 0.14% |
| New England Research & Management, Inc. | 8,875 | $225 | 0.13% |
| Jump Financial, LLC | 129,067 | $3,266,686 | 0.12% |
| LORD, ABBETT & CO. LLC | 1,248,586 | $31,601 | 0.11% |
| Summit X, LLC | 16,787 | $425,079 | 0.10% |
| INNOVIS ASSET MANAGEMENT LLC | 10,517 | $266,186 | 0.10% |
| Holocene Advisors, LP | 842,563 | $21,325,270 | 0.09% |
| TWINBEECH CAPITAL LP | 171,166 | $4,332,211 | 0.09% |
| Quantbot Technologies LP | 51,118 | $1,293,797 | 0.08% |
| NinePointTwo Capital LLC | 8,444 | $213 | 0.08% |
| XTX Topco Ltd | 17,526 | $443,583 | 0.08% |
| BAMCO INC /NY/ | 1,122,666 | $28,414,676 | 0.08% |
| TWO SIGMA ADVISERS, LP | 1,124,000 | $28,448,440 | 0.07% |
External links
This page lists REVANCE THERAPEUTICS INC's shareholders in Q2 2023. To view REVANCE THERAPEUTICS INC's shareholder history, click here.